Review

es cu (MedChemExpress)

Name: es cu
Brand: MedChemExpress
Rating: 96 (130 reviews)

MedChemExpress is a verified supplier

MedChemExpress manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

MedChemExpress es cu

Glycogen metabolism-PPP regulates macrophages phenotype in cuproptosis. a Macrophages were treated <t>with</t> <t>ES-Cu</t> (150 nmol/L, 1:1) for 12 h after <t>1</t> <t>μmol/L</t> MZ-101 pre-treatment for 30 min. The level of glycogen was detected in MZ-101 treated macrophages. NADPH/NADP + ratio ( b ), GSH/GSSG ratio ( c ) and ROS level ( d ) were analyzed. Macrophages were pretreated with GYS1 siRNA and then treated with ES-Cu (150 nmol/L, 1:1) for 12 h. The glycogen level ( e ), NADPH/NADP + ratio ( f ), GSH/GSSG ratio ( g ) and ROS level ( h ) were analyzed. Macrophages were treated with ES-Cu (150 nmol/L, 1:1) after overexpressing GYS1. The glycogen level ( i ), NADPH/NADP + ratio ( j ), GSH/GSSG ratio ( k ) and ROS level ( l ) were analyzed. Data are from three independent experiments. All error bars are mean ± SEM. P values were calculated by 1-way ANOVA followed by Tukey’s multiple-comparison test

Es Cu, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 130 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/es cu/product/MedChemExpress
Average 96 stars, based on 130 article reviews

es cu - by Bioz Stars, 2026-03

96/100 stars

Images

1) Product Images from "Cuproptosis promotes inflammatory osteolysis via GYS1-mediated glycogen metabolism"

Article Title: Cuproptosis promotes inflammatory osteolysis via GYS1-mediated glycogen metabolism

Journal: International Journal of Oral Science

doi: 10.1038/s41368-025-00408-1

Glycogen metabolism-PPP regulates macrophages phenotype in cuproptosis. a Macrophages were treated with ES-Cu (150 nmol/L, 1:1) for 12 h after 1 μmol/L MZ-101 pre-treatment for 30 min. The level of glycogen was detected in MZ-101 treated macrophages. NADPH/NADP + ratio ( b ), GSH/GSSG ratio ( c ) and ROS level ( d ) were analyzed. Macrophages were pretreated with GYS1 siRNA and then treated with ES-Cu (150 nmol/L, 1:1) for 12 h. The glycogen level ( e ), NADPH/NADP + ratio ( f ), GSH/GSSG ratio ( g ) and ROS level ( h ) were analyzed. Macrophages were treated with ES-Cu (150 nmol/L, 1:1) after overexpressing GYS1. The glycogen level ( i ), NADPH/NADP + ratio ( j ), GSH/GSSG ratio ( k ) and ROS level ( l ) were analyzed. Data are from three independent experiments. All error bars are mean ± SEM. P values were calculated by 1-way ANOVA followed by Tukey’s multiple-comparison test

Figure Legend Snippet: Glycogen metabolism-PPP regulates macrophages phenotype in cuproptosis. a Macrophages were treated with ES-Cu (150 nmol/L, 1:1) for 12 h after 1 μmol/L MZ-101 pre-treatment for 30 min. The level of glycogen was detected in MZ-101 treated macrophages. NADPH/NADP + ratio ( b ), GSH/GSSG ratio ( c ) and ROS level ( d ) were analyzed. Macrophages were pretreated with GYS1 siRNA and then treated with ES-Cu (150 nmol/L, 1:1) for 12 h. The glycogen level ( e ), NADPH/NADP + ratio ( f ), GSH/GSSG ratio ( g ) and ROS level ( h ) were analyzed. Macrophages were treated with ES-Cu (150 nmol/L, 1:1) after overexpressing GYS1. The glycogen level ( i ), NADPH/NADP + ratio ( j ), GSH/GSSG ratio ( k ) and ROS level ( l ) were analyzed. Data are from three independent experiments. All error bars are mean ± SEM. P values were calculated by 1-way ANOVA followed by Tukey’s multiple-comparison test

Techniques Used: Comparison

Glycogen metabolism regulates osteoclastogenesis in cuproptosis. a The workflow of in vitro osteoclastogenesis assay for conditioned media collection. b Osteoclasts were induced in conditioned media and then stained for TRAP-positive cells. Scale bar: 100 μm. c The quantification of TRAP-stained polynucleated (≥5 nuclei) osteoclasts that were stimulated with ES-Cu and MZ-101. d The mRNA levels of Acp5 , Oscar , Dcstamp and Fos in BMDMs treated with ES-Cu (150 nmol/L, 1:1) after 1 μmol/L MZ-101 pretreatment. e Western blot analysis of p-Src and MMP9 expression in macrophages after ES-Cu and MZ-101 treatment. Data are from 3 independent experiments. All error bars are mean ± SEM. P values were calculated by 1-way ANOVA followed by Tukey’s multiple-comparison test

Figure Legend Snippet: Glycogen metabolism regulates osteoclastogenesis in cuproptosis. a The workflow of in vitro osteoclastogenesis assay for conditioned media collection. b Osteoclasts were induced in conditioned media and then stained for TRAP-positive cells. Scale bar: 100 μm. c The quantification of TRAP-stained polynucleated (≥5 nuclei) osteoclasts that were stimulated with ES-Cu and MZ-101. d The mRNA levels of Acp5 , Oscar , Dcstamp and Fos in BMDMs treated with ES-Cu (150 nmol/L, 1:1) after 1 μmol/L MZ-101 pretreatment. e Western blot analysis of p-Src and MMP9 expression in macrophages after ES-Cu and MZ-101 treatment. Data are from 3 independent experiments. All error bars are mean ± SEM. P values were calculated by 1-way ANOVA followed by Tukey’s multiple-comparison test

Techniques Used: In Vitro, Staining, Western Blot, Expressing, Comparison

Copper binding to H3K27me3 epigenetically suppresses GYS1 expression. a Schematic diagram illustrating the copper binding with H3K27me3. b Western blot analysis of H3K27me3 expression in ES-Cu treated macrophages. c The co-localization of copper (red) and H3K27me3 (green) was detected by confocal. Scale bar: 5 μm. d ChIP-qPCR for H3K27me3 at the GYS1 promoters in macrophages. e Macrophages were pretreated with 1 μmol/L GSK-4J for 30 min, then treated with ES-Cu (150 nmol/L, 1:1) for 12 h. Western blot analysis of H3K27me3 and GYS1 expression in macrophages. f Cell viability of macrophages was analyzed. g The osteoclasts were induced and the representative images of TRAP staining were shown. Scale bar: 100 μm. h The quantification of TRAP-stained polynucleated (≥5 nuclei) osteoclasts. Data are from 3 independent experiments. All error bars are mean ± SEM. P values were calculated by 1-way ANOVA followed by Tukey’s multiple-comparison test

Figure Legend Snippet: Copper binding to H3K27me3 epigenetically suppresses GYS1 expression. a Schematic diagram illustrating the copper binding with H3K27me3. b Western blot analysis of H3K27me3 expression in ES-Cu treated macrophages. c The co-localization of copper (red) and H3K27me3 (green) was detected by confocal. Scale bar: 5 μm. d ChIP-qPCR for H3K27me3 at the GYS1 promoters in macrophages. e Macrophages were pretreated with 1 μmol/L GSK-4J for 30 min, then treated with ES-Cu (150 nmol/L, 1:1) for 12 h. Western blot analysis of H3K27me3 and GYS1 expression in macrophages. f Cell viability of macrophages was analyzed. g The osteoclasts were induced and the representative images of TRAP staining were shown. Scale bar: 100 μm. h The quantification of TRAP-stained polynucleated (≥5 nuclei) osteoclasts. Data are from 3 independent experiments. All error bars are mean ± SEM. P values were calculated by 1-way ANOVA followed by Tukey’s multiple-comparison test

Techniques Used: Binding Assay, Expressing, Western Blot, ChIP-qPCR, Staining, Comparison

The disruption of glycogen metabolism intensifies cuproptosis and inflammatory bone loss in vivo. a Schematic illustration of the mouse calvarial osteolysis experimental procedure. ES-Cu (30 μmol/kg, 1:1) was administered daily to the calvaria of mice for 7 days, and mice were randomly assigned to receive TTM (4 mmol/kg) or MZ-101 (0.2 mmol/kg) via intraperitoneal injection every other day. b Representative micro-computed tomography (micro-CT) images of calvarial bones. Scale bars: 500 μm ( n = 6). c Representative images of H&E, TRAP and anti-DLAT body staining at calvarial bones. Scale bars of H&E and TRAP: 100 μm. Scale bar of DLAT: 50 μm ( n = 6)

Figure Legend Snippet: The disruption of glycogen metabolism intensifies cuproptosis and inflammatory bone loss in vivo. a Schematic illustration of the mouse calvarial osteolysis experimental procedure. ES-Cu (30 μmol/kg, 1:1) was administered daily to the calvaria of mice for 7 days, and mice were randomly assigned to receive TTM (4 mmol/kg) or MZ-101 (0.2 mmol/kg) via intraperitoneal injection every other day. b Representative micro-computed tomography (micro-CT) images of calvarial bones. Scale bars: 500 μm ( n = 6). c Representative images of H&E, TRAP and anti-DLAT body staining at calvarial bones. Scale bars of H&E and TRAP: 100 μm. Scale bar of DLAT: 50 μm ( n = 6)

Techniques Used: Disruption, In Vivo, Injection, Micro-CT, Staining

Image Search Results

Journal: International Journal of Oral Science

Article Title: Cuproptosis promotes inflammatory osteolysis via GYS1-mediated glycogen metabolism

doi: 10.1038/s41368-025-00408-1

Figure Lengend Snippet: Glycogen metabolism-PPP regulates macrophages phenotype in cuproptosis. a Macrophages were treated with ES-Cu (150 nmol/L, 1:1) for 12 h after 1 μmol/L MZ-101 pre-treatment for 30 min. The level of glycogen was detected in MZ-101 treated macrophages. NADPH/NADP + ratio ( b ), GSH/GSSG ratio ( c ) and ROS level ( d ) were analyzed. Macrophages were pretreated with GYS1 siRNA and then treated with ES-Cu (150 nmol/L, 1:1) for 12 h. The glycogen level ( e ), NADPH/NADP + ratio ( f ), GSH/GSSG ratio ( g ) and ROS level ( h ) were analyzed. Macrophages were treated with ES-Cu (150 nmol/L, 1:1) after overexpressing GYS1. The glycogen level ( i ), NADPH/NADP + ratio ( j ), GSH/GSSG ratio ( k ) and ROS level ( l ) were analyzed. Data are from three independent experiments. All error bars are mean ± SEM. P values were calculated by 1-way ANOVA followed by Tukey’s multiple-comparison test

Article Snippet: ES-Cu (40 μmol/kg, 1:1; Elesclomol, MedChemExpress, HY-12040; CuCl 2 , Aladdin, C106775) was injected into the dental pulp cavity.

Techniques: Comparison

Journal: International Journal of Oral Science

Article Title: Cuproptosis promotes inflammatory osteolysis via GYS1-mediated glycogen metabolism

doi: 10.1038/s41368-025-00408-1

Figure Lengend Snippet: Glycogen metabolism regulates osteoclastogenesis in cuproptosis. a The workflow of in vitro osteoclastogenesis assay for conditioned media collection. b Osteoclasts were induced in conditioned media and then stained for TRAP-positive cells. Scale bar: 100 μm. c The quantification of TRAP-stained polynucleated (≥5 nuclei) osteoclasts that were stimulated with ES-Cu and MZ-101. d The mRNA levels of Acp5 , Oscar , Dcstamp and Fos in BMDMs treated with ES-Cu (150 nmol/L, 1:1) after 1 μmol/L MZ-101 pretreatment. e Western blot analysis of p-Src and MMP9 expression in macrophages after ES-Cu and MZ-101 treatment. Data are from 3 independent experiments. All error bars are mean ± SEM. P values were calculated by 1-way ANOVA followed by Tukey’s multiple-comparison test

Article Snippet: ES-Cu (40 μmol/kg, 1:1; Elesclomol, MedChemExpress, HY-12040; CuCl 2 , Aladdin, C106775) was injected into the dental pulp cavity.

Techniques: In Vitro, Staining, Western Blot, Expressing, Comparison

Journal: International Journal of Oral Science

Article Title: Cuproptosis promotes inflammatory osteolysis via GYS1-mediated glycogen metabolism

doi: 10.1038/s41368-025-00408-1

Figure Lengend Snippet: Copper binding to H3K27me3 epigenetically suppresses GYS1 expression. a Schematic diagram illustrating the copper binding with H3K27me3. b Western blot analysis of H3K27me3 expression in ES-Cu treated macrophages. c The co-localization of copper (red) and H3K27me3 (green) was detected by confocal. Scale bar: 5 μm. d ChIP-qPCR for H3K27me3 at the GYS1 promoters in macrophages. e Macrophages were pretreated with 1 μmol/L GSK-4J for 30 min, then treated with ES-Cu (150 nmol/L, 1:1) for 12 h. Western blot analysis of H3K27me3 and GYS1 expression in macrophages. f Cell viability of macrophages was analyzed. g The osteoclasts were induced and the representative images of TRAP staining were shown. Scale bar: 100 μm. h The quantification of TRAP-stained polynucleated (≥5 nuclei) osteoclasts. Data are from 3 independent experiments. All error bars are mean ± SEM. P values were calculated by 1-way ANOVA followed by Tukey’s multiple-comparison test

Article Snippet: ES-Cu (40 μmol/kg, 1:1; Elesclomol, MedChemExpress, HY-12040; CuCl 2 , Aladdin, C106775) was injected into the dental pulp cavity.

Techniques: Binding Assay, Expressing, Western Blot, ChIP-qPCR, Staining, Comparison

Journal: International Journal of Oral Science

Article Title: Cuproptosis promotes inflammatory osteolysis via GYS1-mediated glycogen metabolism

doi: 10.1038/s41368-025-00408-1

Figure Lengend Snippet: The disruption of glycogen metabolism intensifies cuproptosis and inflammatory bone loss in vivo. a Schematic illustration of the mouse calvarial osteolysis experimental procedure. ES-Cu (30 μmol/kg, 1:1) was administered daily to the calvaria of mice for 7 days, and mice were randomly assigned to receive TTM (4 mmol/kg) or MZ-101 (0.2 mmol/kg) via intraperitoneal injection every other day. b Representative micro-computed tomography (micro-CT) images of calvarial bones. Scale bars: 500 μm ( n = 6). c Representative images of H&E, TRAP and anti-DLAT body staining at calvarial bones. Scale bars of H&E and TRAP: 100 μm. Scale bar of DLAT: 50 μm ( n = 6)

Article Snippet: ES-Cu (40 μmol/kg, 1:1; Elesclomol, MedChemExpress, HY-12040; CuCl 2 , Aladdin, C106775) was injected into the dental pulp cavity.

Techniques: Disruption, In Vivo, Injection, Micro-CT, Staining

Review

Structured Review

Images

1) Product Images from "Cuproptosis promotes inflammatory osteolysis via GYS1-mediated glycogen metabolism"

Similar Products

Image Search Results